Comments
Loading...

Aethlon Medical Earnings Estimates

AEMDNASDAQ
Logo brought to you by Benzinga Data
$0.4611
-0.03-5.51%
Pre-Market: 8:41 AM EDT

Aethlon Medical Earnings Estimates, EPS & Revenue | NASDAQ:AEMD | Benzinga

Aethlon Medical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Feb 12
EPS
$-0.130
Quarterly Revenue
$0.00
Annual Revenue
(as of Dec 31)

Analyze the earnings history of Aethlon Medical using advanced sorting and filters.

Data brought to you by Benzinga APIs

Aethlon Medical (AEMD) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q32025-02-12$-0.13$-0.2035.0 %
Q22024-11-13$-0.20$-0.19-5.26 %
Q12024-08-14$-0.34$-0.31-9.68 %
Q42024-06-27$-0.91$-1.2326.0 %

Aethlon Medical (AEMD) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q32023-02-13$0$3.17M-100.0 %
Q22022-11-14$0$70.00K-100.0 %
Q12022-08-09$0$70.00K-100.0 %
Q42022-06-28$13.12K$720.00K-98.2 %

FAQ

Q

When is Aethlon Medical (NASDAQ:AEMD) reporting earnings?

A

Aethlon Medical (AEMD) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 12, 2025 for Q3.

Q

What were the latest earnings per share (EPS) for Aethlon Medical (NASDAQ:AEMD)?

A

Aethlon Medical (AEMD) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 12, 2025 for Q3 and the Actual EPS was $-0.13, which beat the estimate of $-0.20.

Q

What were Aethlon Medical’s (NASDAQ:AEMD) revenues?

A

Aethlon Medical (AEMD) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 12, 2025 for Q3 and the Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch